Showing results (1181-1190 of 1,221) with videos related to
Sort By:
Pageof 123
Nature Plants|May 28, 2021
Genome structural evolution in Brassica cropsZhesi He, Ruiqin Ji, Lenka Havlickova, et al.Nature Medicine|May 9, 2018
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockadeJianfeng Shen, Zhenlin Ju, Wei Zhao, et al.Molecular Cancer|March 26, 2022
Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trialSong-Yang Wu, Ying Xu, Li Chen, et al.Hepatology International|March 1, 2022
Low platelets: a new and simple prognostic marker for patients with hepatitis E virus-related acute liver failureXiuying Mu, Jun Zou, Jing Chen, et al.Journal of Evidence-Based Medicine|April 6, 2023
Traditional Chinese medicine for frozen shoulder: An evidence-based guidelineXiaokuan Qin, Kai Sun, Yingfang Ao, et al.Cell Death Discovery|December 8, 2025
CircPPFIA2 drives prostate cancer progression and enzalutamide resistance by sponging miR-646 and miR-1200 to upregulate ETS1Yiyou Mao, Qu Leng, Jun Wu, et al.Antioxidants & Redox Signaling|February 10, 2011
Knockdown of Akt1 promotes Akt2 upregulation and resistance to oxidative-stress-induced apoptosis through control of multiple signaling pathwaysLan Zhang, Shuming Sun, Jie Zhou, et al.Journal of Alzheimer'S Disease : JAD|November 29, 2021
The Hubei Memory and Aging Cohort Study: Study Design, Baseline Characteristics, and Prevalence of Cognitive ImpairmentsLin Li, Gui-Rong Cheng, Dan Liu, et al.The Lancet Regional Health. Western Pacific|March 30, 2026
Virologic, immunologic, and metabolic outcomes and mortality in people with HIV on bictegravir/emtricitabine/tenofovir alafenamide fumarate versus dolutegravir-based antiretroviral therapies: a retrospective multicenter cohort study in ChinaXinsheng Wu, Ping Ma, Lianguo Ruan, et al.Cell Discovery|May 13, 2024
Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label studyYunyu Mao, Qibin Liao, Youwei Zhu, et al.Pageof 123